Skip to content

Game Plan for PrEP

Game Plan for PrEP: A Pilot Trial of a Web-based Intervention to Help High-risk Men on PrEP Adhere to Their Medication, Reduce Alcohol Use, and Encourage Safe Sex

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04973267
Enrollment
73
Registered
2021-07-22
Start date
2021-07-01
Completion date
2023-02-28
Last updated
2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol; Harmful Use, Human Immunodeficiency Virus Exposure

Keywords

PrEP, Alcohol Use, HIV, STIs, LGBTQ

Brief summary

This small pilot randomized controlled trial will test whether a brief, web-based intervention inspired by the principles of motivational interviewing helps high-risk men who take pre-exposure prophylaxis (PrEP) moderate their alcohol use, and improve key outcomes of PrEP care, including adherence, persistence, and STI rates. Men with a history of lapses in PrEP adherence will be randomly assigned to either (1) use the web-based intervention, called Game Plan for PrEP, or (2) watch video clips encouraging healthy lifestyles (e.g., sleep hygiene, balanced diet; attention-matched control). Participants will complete STI testing and submit dried blood spot (DBS) samples to facilitate analyses of alcohol use and PrEP adherence biomarkers at baseline, 3-months, and 6-months during the study period. Participants will also complete online surveys at baseline, 1-month, 3-months, and 6-months during the study period.

Detailed description

This small, pilot randomized controlled trial will explore preliminary evidence for the efficacy of Game Plan for PrEP, a brief, web-based intervention inspired by brief motivational interventions. The study will test whether Game Plan for PrEP is efficacious in reducing heavy drinking and sexually-transmitted infection (STI) incidence, and improving PrEP adherence/persistence, among heavy drinking men who have sex with men who are on PrEP, but who report a recent history of missing 3 or more consecutive doses in the past month. In this study, we will randomize 50 gay and bisexual men to receive either (1) Game Plan for PrEP (GP4PrEP) or (2) an attention-matched control at the same PrEP care/monitoring visit that they reported meeting eligibility criteria. We will use self-report measures of alcohol use collected at 1-, 3-, and 6-months and changes in a biomarker of alcohol use collected at baseline, 3-, and 6-months to explore whether Game Plan for PrEP reduces binge drinking compared with control. We will also use data from a biomarker of PrEP adherence to explore whether Game Plan for PrEP improves PrEP adherence versus control.

Interventions

BEHAVIORALGame Plan for PrEP

See arm description.

BEHAVIORALAttention-Matched Control Lifestyle Habits Videos

Web-based videos providing information on sleep hygiene and proper diet.

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigators will be blinded to study condition. Staff collecting dried blood spot samples will also be blinded to condition. Participants will be encouraged to complete online surveys using an automated email system, so outcomes assessors will not be present.

Intervention model description

Participants will be randomly assigned 1:1 to one of two conditions: (1) Game Plan for PrEP and (2) an attention-matched control consisting of videos encouraging healthy lifestyle habits.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Current male gender * 18+ years old * Fluent in English * Heavy alcohol use in the past month (\>5 drinks on a single occasion or \>14 drinks in a week) * Currently prescribed and actively taking PrEP * Report missing \> 3 PrEP doses in a row at least once in the past 3 months.

Exclusion criteria

* Reporting a history or risk of complicated alcohol withdrawal * Reporting currently receiving medications or counseling for an alcohol or drug use disorder * Injection drug use in the past year * Positive screen for drug-related disorders

Design outcomes

Primary

MeasureTime frameDescription
Number of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 1, Month 3, and Month 6The total number of days on which participants reported drinking 5+ drinks in a single day over the past 30 days
Persistence With Pre-exposure Prophylaxis (PrEP)Past 6 monthsWhether or not participants explicitly stopped taking PrEP at some point during the 6-month study period
Number of Alcohol Drinking DaysMonth 1, Month 3, and Month 6The total number of days in which participants reported drinking alcohol in the past 30 days
Average Number of Drinks Consumed Per Drinking DayMonth 1, Month 3, and Month 6The average number of standard alcoholic drinks consumed when participants reported drinking over the past 30 days
Pre-exposure Prophylaxis (PrEP) Lapse Days6 monthsNumber of participants who reported missing 4+ consecutive days of PrEP doses

Secondary

MeasureTime frameDescription
Phosphatidylethanol LevelMonth 3 and Month 6The quantity of phosphatidylethanol (PEth) detected in dried blood spot samples collected at 3- and 6-months, ng/mL
Tenofovir Diphosphate AdherenceMonth 3 and Month 6The predicted probability of tenofovir diphosphate adherence (\>= 4 doses/week) detected in dried blood spot samples collected at 3- and 6-months
Any Sexually-transmitted Infection (STI) Diagnosis6 Months

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Participants will be asked to use Game Plan for PrEP for however long they wish. Game Plan for PrEP is a web-based intervention that provides users with feedback about how much their risk for HIV is reduced on PrEP, their risk for bacterial STIs, and helps them make a plan to take their medication regularly and reduce their risk for STIs. Game Plan for PrEP also providers users with feedback about their alcohol use compared to others in their age group and encourages them to make a plan to reduce it.
37
Control
Participants in this condition will view several videos that encourage them to adopt sleep hygiene and healthy diet behaviors. The videos were selected to last as long as the average time users engage with Game Plan for PrEP in its initial modules. Attention-Matched Control Lifestyle Habits Videos: Web-based videos providing information on sleep hygiene and proper diet.
36
Total73

Baseline characteristics

CharacteristicInterventionControlTotal
Age, Continuous33.4 years
STANDARD_DEVIATION 7.4
37.4 years
STANDARD_DEVIATION 10
35.4 years
STANDARD_DEVIATION 9
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants9 Participants18 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants27 Participants55 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
4 Participants4 Participants8 Participants
Race (NIH/OMB)
More than one race
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
30 Participants30 Participants60 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
37 Participants36 Participants73 Participants
Years on PrEP2.7 years
STANDARD_DEVIATION 2.2
2.5 years
STANDARD_DEVIATION 2.2
2.6 years
STANDARD_DEVIATION 2.1

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 36
other
Total, other adverse events
0 / 370 / 36
serious
Total, serious adverse events
0 / 370 / 36

Outcome results

Primary

Average Number of Drinks Consumed Per Drinking Day

The average number of standard alcoholic drinks consumed when participants reported drinking over the past 30 days

Time frame: Month 1, Month 3, and Month 6

ArmMeasureGroupValue (MEAN)Dispersion
InterventionAverage Number of Drinks Consumed Per Drinking DayMonth 13.89 standard drinksStandard Error 0.36
InterventionAverage Number of Drinks Consumed Per Drinking DayMonth 34.37 standard drinksStandard Error 0.37
InterventionAverage Number of Drinks Consumed Per Drinking DayMonth 63.94 standard drinksStandard Error 0.37
ControlAverage Number of Drinks Consumed Per Drinking DayMonth 14.02 standard drinksStandard Error 0.37
ControlAverage Number of Drinks Consumed Per Drinking DayMonth 34.60 standard drinksStandard Error 0.37
ControlAverage Number of Drinks Consumed Per Drinking DayMonth 64.49 standard drinksStandard Error 0.4
Primary

Number of Alcohol Drinking Days

The total number of days in which participants reported drinking alcohol in the past 30 days

Time frame: Month 1, Month 3, and Month 6

ArmMeasureGroupValue (MEAN)Dispersion
InterventionNumber of Alcohol Drinking DaysMonth 67.21 daysStandard Error 0.97
InterventionNumber of Alcohol Drinking DaysMonth 19.98 daysStandard Error 1.29
InterventionNumber of Alcohol Drinking DaysMonth 39.12 daysStandard Error 1.2
ControlNumber of Alcohol Drinking DaysMonth 69.25 daysStandard Error 1.28
ControlNumber of Alcohol Drinking DaysMonth 111.38 daysStandard Error 1.49
ControlNumber of Alcohol Drinking DaysMonth 37.49 daysStandard Error 1.03
Primary

Number of Heavy Drinking Days (5+ Drinks on a Single Occasion)

The total number of days on which participants reported drinking 5+ drinks in a single day over the past 30 days

Time frame: Month 1, Month 3, and Month 6

ArmMeasureGroupValue (MEAN)Dispersion
InterventionNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 12.70 bring drinking daysStandard Error 0.54
InterventionNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 32.70 bring drinking daysStandard Error 0.55
InterventionNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 62.82 bring drinking daysStandard Error 0.57
ControlNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 13.84 bring drinking daysStandard Error 0.7
ControlNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 32.58 bring drinking daysStandard Error 0.5
ControlNumber of Heavy Drinking Days (5+ Drinks on a Single Occasion)Month 63.65 bring drinking daysStandard Error 0.71
Primary

Persistence With Pre-exposure Prophylaxis (PrEP)

Whether or not participants explicitly stopped taking PrEP at some point during the 6-month study period

Time frame: Past 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionPersistence With Pre-exposure Prophylaxis (PrEP)5 Participants
ControlPersistence With Pre-exposure Prophylaxis (PrEP)7 Participants
Primary

Pre-exposure Prophylaxis (PrEP) Lapse Days

Number of participants who reported missing 4+ consecutive days of PrEP doses

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionPre-exposure Prophylaxis (PrEP) Lapse Days3 Participants
ControlPre-exposure Prophylaxis (PrEP) Lapse Days3 Participants
Secondary

Any Sexually-transmitted Infection (STI) Diagnosis

Time frame: 6 Months

Population: No data were collected

Secondary

Phosphatidylethanol Level

The quantity of phosphatidylethanol (PEth) detected in dried blood spot samples collected at 3- and 6-months, ng/mL

Time frame: Month 3 and Month 6

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPhosphatidylethanol LevelMonth 395.57 ng/mLStandard Error 8.03
InterventionPhosphatidylethanol LevelMonth 672.47 ng/mLStandard Error 8.79
ControlPhosphatidylethanol LevelMonth 377.61 ng/mLStandard Error 8.59
ControlPhosphatidylethanol LevelMonth 693.58 ng/mLStandard Error 9.49
Secondary

Tenofovir Diphosphate Adherence

The predicted probability of tenofovir diphosphate adherence (\>= 4 doses/week) detected in dried blood spot samples collected at 3- and 6-months

Time frame: Month 3 and Month 6

ArmMeasureGroupValue (MEAN)Dispersion
InterventionTenofovir Diphosphate AdherenceMonth 60.76 predicted probabilityStandard Error 0.08
InterventionTenofovir Diphosphate AdherenceMonth 30.68 predicted probabilityStandard Error 0.09
ControlTenofovir Diphosphate AdherenceMonth 30.83 predicted probabilityStandard Error 0.07
ControlTenofovir Diphosphate AdherenceMonth 60.74 predicted probabilityStandard Error 0.08

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026